Magnus Financial Group LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Magnus Financial Group LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2023$6,930
-2.9%
11,0000.0%0.00%0.0%
Q4 2022$7,140
-62.4%
11,0000.0%0.00%
-75.0%
Q3 2022$19,000
+35.7%
11,0000.0%0.00%
+33.3%
Q2 2022$14,000
+100.0%
11,0000.0%0.00%
+200.0%
Q1 2022$7,000
-72.0%
11,000
+10.0%
0.00%
-50.0%
Q4 2020$25,0000.0%10,0000.0%0.00%
-33.3%
Q3 2020$25,000
-24.2%
10,0000.0%0.00%
-25.0%
Q2 2020$33,000
+32.0%
10,0000.0%0.00%
+33.3%
Q1 2020$25,000
-46.8%
10,0000.0%0.00%
-57.1%
Q4 2019$47,000
+9.3%
10,0000.0%0.01%
-12.5%
Q3 2019$43,000
-25.9%
10,0000.0%0.01%
-27.3%
Q2 2019$58,000
+48.7%
10,0000.0%0.01%
+37.5%
Q1 2019$39,00010,0000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders